Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Drugs induced pulmonary arterial hypertension.

Seferian A, Chaumais MC, Savale L, Günther S, Tubert-Bitter P, Humbert M, Montani D.

Presse Med. 2013 Sep;42(9 Pt 2):e303-10. doi: 10.1016/j.lpm.2013.07.005. Epub 2013 Aug 22. Review.

PMID:
23972547
2.

Drug-induced pulmonary arterial hypertension: a recent outbreak.

Montani D, Seferian A, Savale L, Simonneau G, Humbert M.

Eur Respir Rev. 2013 Sep 1;22(129):244-50. doi: 10.1183/09059180.00003313. Review.

3.

Drug-induced pulmonary arterial hypertension: a review.

Garg L, Akbar G, Agrawal S, Agarwal M, Khaddour L, Handa R, Garg A, Shah M, Patel B, Dalal BD.

Heart Fail Rev. 2017 May;22(3):289-297. doi: 10.1007/s10741-017-9612-9. Review.

PMID:
28417295
4.
5.
6.

Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report.

Hagiwara M, Tsuchida A, Hyakkoku M, Nishizato K, Asai T, Nozawa Y, Tsuchihashi K, Shimamoto K.

Jpn Circ J. 2000 Mar;64(3):218-21.

7.

In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension.

Baumgart B, Guha M, Hennan J, Li J, Woicke J, Simic D, Graziano M, Wallis N, Sanderson T, Bunch RT.

Cancer Chemother Pharmacol. 2017 Apr;79(4):711-723. doi: 10.1007/s00280-017-3264-2. Epub 2017 Mar 10.

PMID:
28283735
8.

Pulmonary hypertension associated with benfluorex exposure.

Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jaïs X, Montani D, Sitbon O, Simonneau G, Humbert M.

Eur Respir J. 2012 Nov;40(5):1164-72. doi: 10.1183/09031936.00188611. Epub 2012 Apr 20.

9.

Idiopathic pulmonary arterial hypertension.

Souza R, Jardim C, Humbert M.

Semin Respir Crit Care Med. 2013 Oct;34(5):560-7. doi: 10.1055/s-0033-1355439. Epub 2013 Sep 13.

PMID:
24037625
10.

Drug-associated pulmonary arterial hypertension.

McGee M, Whitehead N, Martin J, Collins N.

Clin Toxicol (Phila). 2018 Mar 6:1-9. doi: 10.1080/15563650.2018.1447119. [Epub ahead of print]

PMID:
29508628
12.

Temporal trends and drug exposures in pulmonary hypertension: an American experience.

Walker AM, Langleben D, Korelitz JJ, Rich S, Rubin LJ, Strom BL, Gonin R, Keast S, Badesch D, Barst RJ, Bourge RC, Channick R, Frost A, Gaine S, McGoon M, McLaughlin V, Murali S, Oudiz RJ, Robbins IM, Tapson V, Abenhaim L, Constantine G.

Am Heart J. 2006 Sep;152(3):521-6.

PMID:
16923424
13.

The serotonin hypothesis of pulmonary hypertension revisited.

Maclean MR, Dempsie Y.

Adv Exp Med Biol. 2010;661:309-22. doi: 10.1007/978-1-60761-500-2_20. Review.

PMID:
20204739
14.

[Drug-induced Pulmonary Hypertension - a Current Review].

Günther S, Behr J, Knoop H.

Pneumologie. 2016 May;70(5):320-7. doi: 10.1055/s-0041-108315. Epub 2016 Apr 7. Review. German.

PMID:
27055781
15.

[Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].

Goldstein SE, Levy Y, Shoenfeld Y.

Harefuah. 1998 Dec 1;135(11):489-92, 568. Hebrew.

PMID:
10911459
16.

Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.

de Jesus Perez V, Kudelko K, Snook S, Zamanian RT.

Int J Clin Pract Suppl. 2011 Jan;(169):8-10. doi: 10.1111/j.1742-1241.2010.02606.x. Review.

PMID:
21176010
17.

YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.

Huh JW, Kim SY, Lee JH, Lee YS.

Pulm Pharmacol Ther. 2011 Dec;24(6):638-46. doi: 10.1016/j.pupt.2011.09.003. Epub 2011 Sep 24.

PMID:
21963997
18.

[Appetite depressants and pulmonary hypertension].

Hellermann J, Salomon F.

Ther Umsch. 1998 Sep;55(9):548-50. German.

PMID:
9789468
19.

Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.

Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R, Lauzon-Joset JF, Breuils-Bonnet S, Tremblay É, Biardel S, Racine C, Courture C, Bonnet P, Majka SM, Deshaies Y, Picard F, Provencher S, Bonnet S.

J Am Heart Assoc. 2013 Jan 16;2(1):e005157. doi: 10.1161/JAHA.112.005157.

20.

Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.

Natali D, Girerd B, Montani D, Soubrier F, Simonneau G, Humbert M, Sitbon O.

Chest. 2011 Oct;140(4):1066-1068. doi: 10.1378/chest.10-2588.

PMID:
21972386

Supplemental Content

Support Center